Research study Program year 2024 Source: CMS Open Payments

Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the

Research payments

$7,178,721

1,382 payments

Through program year 2024, $7,178,721 in research payments was reported against Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the, across 1,382 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$21,612	7
2023	Research	$3,920,689	425
2022	Research	$3,161,354	932
2021	Research	$6,878	3
2020	Research	$68,188	15

Breakdown

Who paid Research payments · program years 2020–2024

GlaxoSmithKline, LLC. $7,178,721 1,382 payments

Who received the money Research payments · program years 2020–2024

University Of Pittsburgh Dept Of Pediatrics Organisation paid for research $1,248,577 47 payments
University of Pittsburgh Physicians Organisation paid for research $780,723 82 payments
Medpharmics LLC Organisation paid for research $715,452 180 payments
Kaiser Foundation Research Organisation paid for research $429,478 26 payments
Velocity Clinical Research INC Organisation paid for research $323,763 23 payments
Kaiser Foundation Research Institute A Division Of Kaiser Foundation Hospitals Organisation paid for research $311,446 37 payments
New Orleans Center For Clinical Research Organisation paid for research $272,128 16 payments
Midwest Childrens Health Research Institute Organisation paid for research $234,652 27 payments
Alliance For Multispecialty Researc Organisation paid for research $181,902 63 payments
National Clinical Research Organisation paid for research $177,263 45 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.